News & Disclosures

Official press releases, regulatory notifications, financial announcements, and corporate disclosures from VVT Med Inc. All material information is filed on SEDAR+ as required by applicable securities law.

Filter:
Commercial

VVT Med Expands into the Dominican Republic, Appointing Antilles Medical as Exclusive Distributor

VVT Med established a Trial Distribution and Evaluation Agreement with Antilles Medical as exclusive distributor of ScleroSafe™ in the Dominican Republic, with an initial purchase order and a structured pathway toward a five-year partnership. The company also announced plans to close a second tranche of its private placement on or about July 20, 2026, with proceeds directed toward expanded global commercialization.

Regulatory

VVT Med Announces Positive Clinical Data for ScleroSafe® Published in Peer-Reviewed Indian Journal of Vascular and Endovascular Surgery

Peer-reviewed results show the ScleroSafe catheter-directed sclerotherapy system achieved 95% vein occlusion at 30 days with no serious adverse events across 30 patients at Holy Spirit Hospital in Mumbai. The publication validates the technology's efficacy as a non-thermal, non-tumescent treatment for varicose veins.

Commercial

VVT Med Signs Largest European Distribution Agreement to Date; Distributor Joins as Investor

VVT Med secured an exclusive five-year distribution partnership with Uber Ros S.p.A. covering Italy, Vatican City, and San Marino, representing approximately CAD $2.3 million in minimum purchase commitments. The distributor also joined the company's private placement financing, demonstrating strategic confidence in VVT Med's NT-NT technology platform.

Disclosure Notice: All material news affecting the Company is filed as a news release on SEDAR+ and disseminated to newswire services in accordance with TSXV continuous disclosure requirements. The list above may not be exhaustive; search SEDAR+ for the complete disclosure record.